Haisco Pharmaceutical Group Co Ltd
SZSE:002653

Watchlist Manager
Haisco Pharmaceutical Group Co Ltd Logo
Haisco Pharmaceutical Group Co Ltd
SZSE:002653
Watchlist
Price: 34.59 CNY -4.45% Market Closed
Market Cap: 38.7B CNY
Have any thoughts about
Haisco Pharmaceutical Group Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

76.3
Current
129.2
Median
13.3
Industry
Lower than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
76.3
=
Enterprise Value
38.6B CNY
/
EBITDA
506.5m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
54.6
2-Years Forward
EV/EBITDA
40.9
3-Years Forward
EV/EBITDA
32.5

See Also

Discover More